NCT00709787

Brief Summary

To assess the pattern of hypertension in the population in terms of presence of additional risk factors (ARF) and cardiovascular risk stratification.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
899

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2008

Shorter than P25 for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 1, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 3, 2008

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2009

Completed
Last Updated

January 27, 2021

Status Verified

January 1, 2021

Enrollment Period

8 months

First QC Date

July 1, 2008

Last Update Submit

January 26, 2021

Conditions

Hypertension

Keywords

Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication

Outcome Measures

Primary Outcomes (1)

  • Description of hypertensive patients in terms of presence of associated cardiovascular (CV) risk factors (number of additional CV risk factors and frequency)

Secondary Outcomes (3)

  • Description of pattern of management of HT and CVD prevention, through lifestyle and use of drug therapies,

  • Estimate adherence to treatment using the Morisky Adherence Scale (MAS)

  • Estimation of hypertensive patients CV risk stratification based on ESH/ESC Hypertension Guidelines 2007 and to compare it with physicians' estimation of CV risk.

Study Arms (1)

Hypertensive Subjects undergoing primary prevention

Other: Usual Care

Interventions

Usual CareOTHER

Normal care for hypertensive patients with risk factors for CHD

Hypertensive Subjects undergoing primary prevention

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult Hypertensive Patients managed in primary care

You may qualify if:

  • Age 18 to 80 years old
  • Patients with hypertension: newly diagnosed and /or already diagnosed and treated , whether at goal or not for the blood pressure level;
  • Patients with no history of CHD/CVD

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pfizer Investigational Site

Varaždin, 42000, Croatia

Location

Pfizer Investigational Site

Prague, 140 00, Czechia

Location

MeSH Terms

Conditions

HypertensionCoronary Disease

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesMyocardial IschemiaHeart Diseases

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2008

First Posted

July 3, 2008

Study Start

June 1, 2008

Primary Completion

February 1, 2009

Study Completion

February 1, 2009

Last Updated

January 27, 2021

Record last verified: 2021-01

Locations

CZ(1)CR(1)